Navigation Links
Mylan's Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla(R) HIV Treatment
Date:8/18/2009

PITTSBURGH, Aug. 18 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that Matrix Laboratories, an Indian company in which Mylan owns a controlling stake, has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for a fixed-dose combination (FDC) of Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Tablets, 600 mg/200 mg/300 mg. This is the first and only generic version of this product and will be eligible for purchase outside the U.S. in many developing countries.

Mylan President Heather Bresch said: "This critical approval only further strengthens Mylan and Matrix's efforts to expand access to life-saving, affordable AIDS treatments for people living with HIV/AIDS in developing countries. Matrix's generic fixed-dose combination will dramatically improve access to this more patient-friendly medication while reducing the cost of treatment. Our commitment to growing Matrix's ARV (antiretroviral) franchise goes hand-in-hand with our desire to raise the standard of care in developing countries to the levels available in countries like the U.S."

The Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate FDC is the generic version of Gilead Sciences' Atripla(R) Tablets, which are indicated for the treatment of HIV-1 infection in adults. It combines three anti-AIDS medicines into a single daily dose for either first- or second-line treatment and is one of the best-selling AIDS products in developed countries, with approximately $1.6 billion in U.S. sales alone for the twelve months ending June 30, according to IMS Health. Until now, a generic version of this product has not been available in any market. Cocktails co
'/>"/>

SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Sigma-Aldrich Offers Customizable Synthetic Extracellular Matrix for Stem Cell Research
2. Matrixx Initiatives, Inc. Sets Time for Discussion of First Quarter Fiscal 2010 Financial Results
3. MedInsights Partners With myMatrixx(TM) for Workers Compensation Pharmacy Benefit Management
4. Matrixx Initiatives Confirms Voluntary Recall of Zicam Cold Remedy Nasal Gel, Zicam Cold Remedy Gel Swabs
5. Matrixx Initiatives, Inc. Sets Time for Discussion of Recent FDA Action
6. Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel
7. Matrixx Initiatives, Inc. Received a Warning Letter From the Food and Drug Administration
8. Mylan Announces Successful Matrix Delisting Offer
9. Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting
10. Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46
11. CorMatrix Cardiovascular to Present on its ECM Technology(TM) at the Annual Advanced Cardiac Techniques in Surgery (ACTS) Symposium in New York, N.Y.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... The U.S. Pharmacopeial Convention is pleased to announce that ... at North Carolina State’s College of Veterinary Medicine has ... for Distinguished Volunteer Service—the organization’s highest award. , ... volunteer experts to direct its work to improve the ...
(Date:1/22/2015)... January 22, 2015 Gabe’s Chemo Duck Program is ... the first app ever created for kids with cancer. The Chemo ... and devices, is filled with enjoyable games to help children of ... The free app helps to keep kids entertained, educated and at ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) ... to “Live Fearless.” , The “Faces of Fearless” ... about how they or someone they know has faced a ... the moment. By telling these types of stories through livefearlessmn.com, ...
(Date:1/22/2015)... 2015 Thousand of GranuFlo lawsuits ( ... its GranuFlo and NaturaLyte dialysis concentrates continue to move ... District Court, District of Massachusetts, Bernstein Liebhard LLP reports. ... has remanded a case filed by the state of ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... finds that white women more frequently take more of ... cancer than African-American women. , African-Americans whose cancer ... to have adjuvant cancer therapy than white women, the ... remaining cancer cells, in addition to the primary therapy. ...
... months, a,perfect storm of new technology and research has ... genetics, writes Lee Silver, a professor,of molecular biology at ... is the result of an incredibly complex interplay,among the ... and even the vast stretches of "junk DNA" once ...
... a,transcript of a radio address by President Bush to ... important commitment of the Federal government is to help ... these children are,covered by Medicaid, which will spend more ... children who do not qualify for Medicaid, but whose,families ...
... Oct. 5 Marion Jones-Thompson, 31,of Austin, Texas, ... to federal agencies in connection with two investigations,conducted ... and the Northern,District of California, respectively; Michael J. ... of New York; and Scott N. Schools, the,United ...
... Why: According to the Department of Defense, the signature wound ... the conflicts in Iraq and Afghanistan ... survivors at risk of TBI. Government reports cite nearly ... service members with the potential ...
... Treatment, Physician Program at Montefiore Will, Measure Everything from ... YORK, Oct. 5 Thousands of heart patients,in the ... care in an innovative cardiovascular program in which physicians ... based on 60,performance measures for outpatient and inpatient care. ...
Cached Medicine News:Health News:Whites take supplemental breast cancer therapy more often than blacks 2Health News:NEWSWEEK International Editions: Highlights and Exclusives, OCT. 15, 2007 Issue 2Health News:NEWSWEEK International Editions: Highlights and Exclusives, OCT. 15, 2007 Issue 3Health News:NEWSWEEK International Editions: Highlights and Exclusives, OCT. 15, 2007 Issue 4Health News:Radio Address by President Bush to the Nation 2Health News:Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations 2Health News:Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations 3Health News:Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations 4Health News:Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations 5Health News:Easter Seals Launches Program for Veterans Returning from Iraq and Afghanistan with Traumatic Brain Injuries 2Health News:Easter Seals Launches Program for Veterans Returning from Iraq and Afghanistan with Traumatic Brain Injuries 3Health News:Novel Approach to Improving Cardiovascular Care 2Health News:Novel Approach to Improving Cardiovascular Care 3Health News:Novel Approach to Improving Cardiovascular Care 4
(Date:1/23/2015)... 23, 2015 For the pharmaceutical industry, marketplace success is ... Likewise, the importance of the managed markets function - which ... grow as payer formularies and provider networks play an increasingly ... the same time, managed markets leaders must continually identify the ...
(Date:1/23/2015)... 23, 2015 Research and Markets ( http://www.researchandmarkets.com/research/5dh22x/urinary_catheters ... Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and ... Size, Share, Growth, Trends and Forecast 2014 - 2020" ... At present, the global market for urinary catheters is ...
(Date:1/23/2015)... ( www.medscope.org ), the leading provider of medical alert ... World magazine Connected World Award for its new ... used anywhere, anytime. The nomination was made by RacoWireless, ... MedScope, Landon Garner , Director of Marketing of ...
Breaking Medicine Technology:As Payer Influence Rises, Pharmaceutical Companies work to Optimize the Managed Markets Function 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2
... DIEGO, Sept. 29, 2011 Verinata Health, Inc., a ... announced it has signed a three-year supply agreement with ... sciences tools for the large-scale analysis of genetic variation ... agreement, Verinata Health will purchase Illumina,s sequencing instruments and ...
... Sept. 29, 2011 Reportlinker.com announces that ... in its catalogue: Global ... http://www.reportlinker.com/p098399/Global-Radiation-Therapy-Equipment-Industry.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Devices This report ... Equipment in US$ Million by the following ...
Cached Medicine Technology:Verinata Health Announces a Multi-Year Supply Agreement with Illumina in the Field of Non-Invasive Prenatal Diagnostics 2Global Radiation Therapy Equipment Industry 2Global Radiation Therapy Equipment Industry 3Global Radiation Therapy Equipment Industry 4Global Radiation Therapy Equipment Industry 5Global Radiation Therapy Equipment Industry 6Global Radiation Therapy Equipment Industry 7Global Radiation Therapy Equipment Industry 8Global Radiation Therapy Equipment Industry 9Global Radiation Therapy Equipment Industry 10Global Radiation Therapy Equipment Industry 11Global Radiation Therapy Equipment Industry 12Global Radiation Therapy Equipment Industry 13Global Radiation Therapy Equipment Industry 14Global Radiation Therapy Equipment Industry 15Global Radiation Therapy Equipment Industry 16Global Radiation Therapy Equipment Industry 17Global Radiation Therapy Equipment Industry 18Global Radiation Therapy Equipment Industry 19Global Radiation Therapy Equipment Industry 20Global Radiation Therapy Equipment Industry 21Global Radiation Therapy Equipment Industry 22Global Radiation Therapy Equipment Industry 23Global Radiation Therapy Equipment Industry 24
... temperature set by means of a ... button. A green LED indicates the ... amber LED indicates the unit has ... LED and an audible alarm indicates ...
Provides outstanding patient warming and safety throughout the hospital and is nearly half the size and one-third the weight of earlier units....
The QuickVue Advance® G. vaginalis test is an enzyme activity test for use in the detection of Gardnerella vaginalis Proline IminoPeptidase(PIP) activity in vaginal fluid specimens from women su...
The Affirm™ VPIII tests RNA probe technology offers a dependable, rapid means toward early identification and treatment of patients suffering from these pathogens....
Medicine Products: